Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy (E. P. Kwiatkowska-Borowczyk, A. Kozłowska, K. Maruszak, L. Kańczuga-Koda, M. Koda, M. Dajnowiec, A. Mackiewicz, & D. W. Kowalczyk , Trans.). (2014). Journal of Medical Science, 83(1), 21-28. https://doi.org/10.20883/medical.e39